DrugPatentWatch Database Preview
Drugs in Development Information for Butylphthalide
» See Plans and Pricing
What is the development status for investigational drug Butylphthalide?
Butylphthalide is an investigational drug.
There have been 15 clinical trials for Butylphthalide.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 5th 2019.
The most common disease conditions in clinical trials are Stroke, Ischemia, and Cerebral Infarction. The leading clinical trial sponsors are CSPC-NBP Pharmaceutical Co., Ltd., Peking Union Medical College Hospital, and The Second Hospital of Hebei Medical University.
Summary for Butylphthalide
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 164 |
| WIPO Patent Applications | 191 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 3 (2019-05-05) |
| Vendors | 58 |
Recent Clinical Trials for Butylphthalide
| Title | Sponsor | Phase |
|---|---|---|
| NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy | CSPC-NBP Pharmaceutical Co., Ltd. | Phase 2 |
| NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy | Conjupro Biotherapeutics, Inc. | Phase 2 |
| NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events | Peking University International Hospital | Phase 3 |
Clinical Trial Summary for Butylphthalide
Top disease conditions for Butylphthalide
Top clinical trial sponsors for Butylphthalide
US Patents for Butylphthalide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
